HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ramsdell, J. W. Articles by Tisi, G. M. Search for Related Content PubMed PubMed Citation Articles by Ramsdell, J. W. Articles by Tisi, G. M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 73, 653-659, Copyright © 1977 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Multiorgan scans for staging lung cancer. Correlation with clinical evaluation

JW Ramsdell, RM Peters, AT Taylor Jr, NP Alazraki and GM Tisi

One hundred consecutive patients with findings suggestive of resectable bronchogenic carcinoma were studied prospectively to determine if routine liver, brain, and bone scans (multiorgan scans) detected metastases which were not suggested by a history, physical examination, and serum chemistries. Multiorgan scans were compared with clinical evaluations in 52 patients found to have operable bronchogenic carcinoma. There was a discordance between scans and clinical evaluations in 25/153 scans (16 per cent). Two of the 22 negative scans in patients with abnormal clinical findings were false negative. Sixteen of the 17 positive scans in patients with normal clinical findings were false positive. One of the 131 scans done in patients with no evidence of metastases on clinical evaluation was true positive. These data indicate that the routine use of multiorgan scans in the initial staging of potentially resectable bronchogenic carcinoma is not justified.

This article has been cited by other articles:

				G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 178S - 201S. [Abstract] [Full Text] [PDF]

				S. Erturan, M. Yaman, G. Aydin, I. Uzel, B. Musellim, and K. Kaynak The Role of Whole-Body Bone Scanning and Clinical Factors in Detecting Bone Metastases in Patients With Non-small Cell Lung Cancer Chest, February 1, 2005; 127(2): 449 - 454. [Abstract] [Full Text] [PDF]

				Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer Ann. Thorac. Surg., February 1, 2001; 71(2): 425 - 433. [Abstract] [Full Text] [PDF]

				J. Deslauriers and J. Gregoire Clinical and Surgical Staging of Non-Small Cell Lung Cancer Chest, April 1, 2000; 117(4_suppl_1): 96S - 103S. [Abstract] [Full Text] [PDF]

				K. Tanaka, K. Kubota, T. Kodama, K. Nagai, and Y. Nishiwaki Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1-2 N0 Ann. Thorac. Surg., September 1, 1999; 68(3): 1039 - 1042. [Abstract] [Full Text] [PDF]

				G. H. Guyatt, D. J. Cook, L. E. Griffith, J. D. Miller, T. R.J. Todd, M. R. Johnston, T. L. Winton, A. G. Casson, R. I. Inculet, G. E. Darling, et al. Surgeons’ assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer Ann. Thorac. Surg., August 1, 1999; 68(2): 309 - 315. [Abstract] [Full Text] [PDF]

				F. E. IV, J. H. Ryu, G. M. Miller, P. H. Luetmer, L. A. Forstrom, O. L. Burnett, C. M. Rowland, S. J. Swensen, and D. E. Midthun Suspected Non–Small Cell Lung Cancer: Incidence of Occult Brain and Skeletal Metastases and Effectiveness of Imaging for Detection—Pilot Study Radiology, April 1, 1999; 211(1): 137 - 145. [Abstract] [Full Text]